A Review on Interstitial Cystitis Syndrome (ICS)

  • Posted on: 1 April 2014
  • By: admin

Pharma Admission

igmpi

pharma admission

igmpi

 

PharmaTutor (April- 2014)
ISSN: 2347 - 7881

 

Received On: 10/02/2014; Accepted On: 20/02/2014; Published On: 01/04/2014

 

Author: M Sushma*, TVV Vidyadhar, R Mohanraj, M Babu
Department of Pharmacy Practice,
Raghavendra Institute of Pharmaceutical Education & Research (RIPER),
Near S.K University, Anantapuramu District, Andhra Pradesh, INDIA.
*sushma.banthi@gmail.com

 

ABSTRACT:
Interstitial cystitis (IC) is an irritative bladder syndrome of multifactorial aetiology and is said to be one of the several conditions that causes bladder pain, which is most commonly seen in women than in men. It is of unknown aetiology. But some factors like autoimmune disorder, Genetic predisposition, Gynaecologic surgery in the past, History of recurrent UTIs. The body's immune system attacks the bladder, similar to other autoimmune conditions. The urologist may use a special scope called a cytoscope to look inside your bladder for inflammation, pinpoint bleeding. Management of IC is done by oral therapy of pentosanpolysulphate, Tricyclic anti-depressants, Anti-histamines, Non-steroidal anti-inflammatory drugs, Bladder analgesics. Whereas intravesical therapy Dimethyl sulphoxide, heparin, Bacillus calmette-Guerin

How to cite this article: M Sushma, TVV Vidyadhar, R Mohanraj, M Babu, A Review on Interstitial Cystitis Syndrome (ICS), PharmaTutor, 2014, 2(4), 31-36

[ABSTRACT WITH CITATION]   [VIEW AS HTML]